ANTIBODIES SPECIFIC FOR CLAUDIN 6 (CLDN6)

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20240092896A1
SERIAL NO

18520242

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides antibodies useful as therapeutics for treating and/or preventing diseases associated with cells expressing Claudin-6 (CLDN6), including tumor-related diseases such as ovarian cancer, lung cancer, gastric cancer, breast cancer, hepatic cancer, pancreatic cancer, skin cancer, malignant melanoma, head and neck cancer, sarcoma, bile duct cancer, cancer of the urinary bladder, kidney cancer, colon cancer, placental choriocarcinoma, cervical cancer, testicular cancer, and uterine cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TRON - TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITÄT MAINZ GEMEINNÜTZIGE GMBHFREILIGRATHSTRASSE 12 MAINZ 55131

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Erdeljan, Michael Hochheim am Main, DE 10 88
Hubner, Bernd Munchen, DE 12 92
Koslowski, Michael Frankfurt, DE 81 888
Kreuzberg, Maria Mainz, DE 22 170
Sahin, Ugur Mainz, DE 331 2329
Türeci, Özlem Mainz, DE 76 516
Walter, Korden Wiesbaden, DE 27 215
Woll, Stefan Nackenheim, DE 19 107

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation